SiBone (NASDAQ:SIBN) vs. Tenon Medical (NASDAQ:TNON) Critical Comparison

Tenon Medical (NASDAQ:TNON) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.

Profitability

This table compares Tenon Medical and SiBone’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-396.26%	-409.04%	-114.60%
SiBone	-11.24%	-12.86%	-9.43%

Risk and Volatility

Tenon Medical has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.

Institutional and Insider Ownership

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by insiders. Comparatively, 4.0% of SiBone shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations for Tenon Medical and SiBone, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1	0	2	0	2.33
SiBone	1	0	5	0	2.67

Tenon Medical currently has a consensus price target of $3.00, suggesting a potential upside of 184.36%. SiBone has a consensus price target of $25.00, suggesting a potential upside of 22.58%. Given Tenon Medical’s higher probable upside, analysts plainly believe Tenon Medical is more favorable than SiBone.

Valuation & Earnings

This table compares Tenon Medical and SiBone”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.28 million	3.57	-$13.67 million	($1.77)	-0.60
SiBone	$193.58 million	4.57	-$30.91 million	($0.51)	-39.99

Tenon Medical has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Summary

SiBone beats Tenon Medical on 10 of the 14 factors compared between the two stocks.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About SiBone

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.